Clinical Trials Logo

Over Weight clinical trials

View clinical trials related to Over Weight.

Filter by:
  • None
  • Page 1

NCT ID: NCT02761538 Recruiting - Over Weight Clinical Trials

Medico-economic Evaluation of Obesity

Start date: September 17, 2015
Phase: N/A
Study type: Interventional

The investigators developed the Aviitam® online platform. The purpose of the project is to test the medico-economic impact related to the utilization of the Aviitam online platform in primary care. Primary objective: To assess the cost-effectiveness at 24 months follow-up of the utilization of the Aviitam® online software in primary care for people with obesity and at least one comorbidity compared to a usual follow-up in primary care. Secondary objectives: Weight loss; quality of life ; blood pressure change; changes in lipid profile, blood glucose and HbA1c; physician satisfaction; patients satisfaction, profiling of patients and data mining analysis on the collected data. Method : Overweight & obese patients with associated comorbidities will receive a 24 months follow-up to assess the impact of the use of the online platform Aviitam®. Practitioners will be randomized by lot between an Aviitam® group and a control group (usual care). A medico-economic analysis will be conducted with a cost-effectiveness analysis and a budget impact analysis. With no hypothesis on the primary endpoint, the calculation of the required number of subjects was based on the quality of life. 150 patients will be included per group Patients of the 2 groups will be assessed at baseline and after 24 months. The first day of each month, each patient included in the study will receive a questionnaire to fill online to evaluate their health care consumption in the previous month and the EQ5D questionnaire , a standardized questionnaire validated in French to assess the effects on health and to be used to calculate cost - utility. Expected results and perspectives Proving the effectiveness of the Aviitam® online program focused on non-drug therapies and therapeutic lifestyle changes for overweight and obesity management with reduced health costs, improvement in quality of life, reduction in weight and improvement of comorbidities. In terms of public health, the use of the platform Aviitam® can be expect to improve management of excess body weight and reduced health costs. Furthermore, Aviitam® could be a valuable tool to support healthcare professionals in outpatient therapeutic education approaches.

NCT ID: NCT02191501 Terminated - Obesity Clinical Trials

Endoscopic Suturing of the Gastric Pylorus to Delay Gastric Emptying and Treat Obesity

Start date: May 7, 2013
Phase: N/A
Study type: Interventional

The purpose of this study is to demonstrate the efficacy and safety of endoscopic suturing of the gastric pylorus to delay gastric emptying and treat obesity.

NCT ID: NCT02063295 Completed - Obesity Clinical Trials

An Efficacy, Safety, and Pharmacokinetics Study of Beloranib in Obese Subjects With Hypothalamic Injury

Start date: April 2014
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the efficacy, safety, and pharmacokinetics of beloranib in obese subjects with hypothalamic injury.

NCT ID: NCT02036996 Recruiting - Sleep Disorders Clinical Trials

Evaluation of EarlySense; a Contact-less Heart and Respiration Rate Monitoring in Sleep Lap Examined

Start date: January 2014
Phase: N/A
Study type: Observational

The objective of this study is to collect heart rate, respiration data and motion data of patients admitted to sleep lab and to determine the current accuracy level of the EarlySense system vs. the standard system, and predicate device for EarlySense (Embla) used in sleep lab in monitoring heart rate and respiration rates monitors (ECG, respiratory belts, oximeter) that are currently used in the sleep lab among different population (Obese, patients with or without apnea, patients with or without arrhythmia). It is emphasized that no interpretations or clinical decisions will be made based on data received from the ES study device.

NCT ID: NCT01818921 Completed - Obesity Clinical Trials

An Efficacy, Safety, and Pharmacokinetics Study of Beloranib in Obese Subjects With Prader-Willi Syndrome

Start date: June 2013
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the efficacy, safety, and pharmacokinetics for certain doses of beloranib in obese subjects with Prader-Willi Syndrome.

NCT ID: NCT01753609 Not yet recruiting - Obesity Clinical Trials

Safety and Performance Evaluation of Tulip Device in Healthy Overweight and Obese Volunteers

Start date: January 2013
Phase: N/A
Study type: Interventional

The study will assess the safety and performance of an intragastric auto-inflating and degradable balloon

NCT ID: NCT01519583 Completed - Blood Pressure Clinical Trials

WalkMore Walking Interventions for Overweight/Obese Postmenopausal Women

Start date: May 2012
Phase: N/A
Study type: Interventional

The WalkMore study will help find out how walking interventions can help overweight/obese postmenopausal women with increased risk of cardiovascular disease lower their blood pressure.

NCT ID: NCT01358890 Completed - Obesity Clinical Trials

Low-Carbohydrate Diet Intervention on Body Weight

Start date: May 2011
Phase: Phase 2/Phase 3
Study type: Interventional

- The primary aim of this study is to determine the adherence of low- carbohydrate among Chinese. - Then compare the effect of low-carbohydrate and traditional Chinese but restricted-calories diet on weight loss and metabolic traits.